Inside Celine Dion’s Fight Against Stiff Person Syndrome & Whether A Cure Could Be Within Reach

Jun 12, 2026 by apost team

When Céline Dion revealed in 2022 that she had been diagnosed with Stiff Person Syndrome, many people were hearing the name of the condition for the very first time. Since then, the rare neurological disorder has become the focus of growing public attention, not only because of its connection to the beloved singer but also because of how devastating it can be for those living with it.

Stiff Person Syndrome, often referred to as SPS, is an autoimmune neurological condition that causes severe muscle stiffness, rigidity, and painful spasms. According to the National Institute of Neurological Disorders and Stroke, the disorder can affect the trunk, abdomen, and limbs, making everyday movement increasingly difficult. Patients may also become highly sensitive to sound, touch, or emotional stress, all of which can trigger painful episodes.

In more advanced cases, SPS can interfere with speech, swallowing, and even breathing. One of the greatest challenges facing patients is that the condition is progressive, meaning symptoms tend to worsen over time.

While some individuals experience symptoms in only one area of the body, others develop a more widespread form that affects parts of the brain, brainstem, and spinal cord. Because the disorder is so rare, treatment options have historically been limited, leaving many patients focused primarily on symptom management rather than long-term improvement.

That reality is one reason Dion’s public advocacy has resonated with so many people. Her openness about the condition has helped shine a spotlight on a disease that previously remained largely unknown outside the medical community.

While Stiff Person Syndrome remains one of the most challenging neurological disorders to treat, researchers may be inching closer to something many patients have been waiting for: hope.

Two years after Dion publicly shared her diagnosis, the Céline Dion Foundation committed $2 million toward advancing research into the condition, helping accelerate studies aimed at finding better treatments.

According to physicians involved in that work, the investment has contributed to what could become a major breakthrough. Dr. Amanda Piquet, one of the doctors treating Dion, recently discussed with WGNTV an emerging approach centered on CAR T-cell therapy, a treatment originally developed for certain cancers. The therapy works by removing a patient’s T-cells and reengineering them to target problematic B-cells within the immune system. Once reintroduced into the body, those modified cells seek out and eliminate the immune cells believed to be contributing to the disease.

Explaining the goal of the treatment, Piquet said:

“When you get those T-cells back, those T-cells are seek and destroy, so they deeply deplete your misbehaving B-cells and then once they do their job, your B-cells come back nice and healthy and basically reset the immune system.”

Early findings presented at the American Academy of Neurology Annual Meeting in April have generated cautious excitement among researchers. The study followed 26 adults living with SPS, and roughly four months after treatment, every participant showed improved walking speed. Perhaps most remarkably, eight of the 12 patients who previously relied on mobility aids were able to stop using them altogether.

Describing one of the outcomes, Piquet shared the result that has many experts paying close attention.

“Sixteen weeks after the therapy, no walker, just walking down the hallway. We saw improvements by 46 percent in patients,” she said. “So just incredible.”

apost.com

Had you heard of Stiff Person Syndrome before Céline Dion shared her diagnosis? Do you think breakthroughs like this could change the future for people living with rare diseases? Let us know, and then pass this on to your family, friends, and other Céline Dion fans out there!